Latest immunotherapy news
Circulating Tumor DNA Linked to Poor Prognosis in HER2-Positive Early Breast Cancer
posted January 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
.jpg)
ASCO GI: Zanidatamab + Chemo Beneficial in HER2-Positive Gastroesophageal Cancer
posted January 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Clonal Hematopoiesis of Indeterminate Potential Linked to CVD Risk
posted January 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
30 mg Peanut Protein Maintenance Ups Threshold of Reactivity Over Strict Avoidance in Peanut-Allergic Children
posted January 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors 
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer 
Omalizumab, Multiallergen OIT Both Viable for Multifood Allergy Treatment Related Articles
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine 
Indefinite-Duration Maintenance Therapy No Better Than Fixed-Duration Therapy in Multiple Myeloma 
Rituximab Noninferior to Ocrelizumab for Newly Diagnosed Relapsing MS 
Aglatimagene Besadenovec + Valacyclovir Ups DFS in Localized Prostate Cancer Monthly Specialist Briefings
Stay Connected
